# Implantation or Injectable Dosage Form New Animal Drugs; Lufenuron Suspension
> **Food and Drug Administration** · Final rule. · Published 1998-06-01 · 63 FR 29551
## Document
- **Document number:** 98-14298
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 29551
- **CFR reference:** 21 CFR 522
- **Publication date:** 1998-06-01
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for subcutaneous use of lufenuron suspension in cats for control of flea populations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/06/01/98-14298/implantation-or-injectable-dosage-form-new-animal-drugs-lufenuron-suspension)
---
*AI Analytics · CC0 1.0*